Prognostic significance of membrane antigens and morphology in chronic lymphocytic leukemia.

Prognostic significance of membrane antigens and morphology in chronic lymphocytic leukemia.

Opis bibliograficzny
Główni autorzy:	Matutes, E, Halsey, J, Morilla, R, Atkinson, S, Marco, J, Richards, S, Catovsky, D, Party, M
Format:	Journal article
Wydane:	1999

Podobne zapisy

The clinical significance of patients' sex in chronic lymphocytic leukemia.
od: Catovsky, D, i wsp.
Wydane: (2014)

The clinical significance of patients’ sex in chronic lymphocytic leukemia
od: Daniel Catovsky, i wsp.
Wydane: (2014-06-01)

Gender as a prognostic factor in CLL. Biological pointers to the improved outcome of women.
od: Catovsky, D, i wsp.
Wydane: (2004)

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
od: Dearden, C, i wsp.
Wydane: (2008)

Common genetic variation contributes significantly to the risk of developing chronic lymphocytic leukemia
od: Maria Chiara Di Bernardo, i wsp.
Wydane: (2013-03-01)

Prognostic factors in the UK LRF CLL4 trial
od: Oscier, D, i wsp.
Wydane: (2006)

High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy
od: Moez Dungarwalla, i wsp.
Wydane: (2008-03-01)

Prognostic factors in the UK LRF CLL4 trial.
od: Oscier, D, i wsp.
Wydane: (2005)

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.
od: Gonzalez, D, i wsp.
Wydane: (2011)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
od: Katerina Sarris, i wsp.
Wydane: (2013-01-01)

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation.
od: Oscier, D, i wsp.
Wydane: (2010)

Ki-67 Antigen; A Valuable Prognostic Biomarker for Chronic Lymphocytic Leukemia
od: Valiollah Mehrzad, i wsp.
Wydane: (2022-01-01)

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
od: David Oscier, i wsp.
Wydane: (2010-10-01)

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
od: Catovsky, D, i wsp.
Wydane: (1989)

Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
od: Skowronska, A, i wsp.
Wydane: (2012)

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.
od: Dearden, C, i wsp.
Wydane: (2011)

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia
od: Nyla A. Heerema, i wsp.
Wydane: (2020-05-01)

The Predominant Prognostic Significance of NOTCH1 Mutation Defined by Emulsion PCR in Chronic Lymphocytic Leukemia
od: Skórka K, i wsp.
Wydane: (2021-05-01)

Biological Prognostic Markers in Chronic Lymphocytic Leukemia
od: Vladimíra Vroblová, i wsp.
Wydane: (2009-01-01)

The distribution of CD45R, CD29 and CD45RO (UCHL1) antigens in mature CD4 positive T-cell leukaemias.
od: Worner, I, i wsp.
Wydane: (1990)

Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.
od: Else, M, i wsp.
Wydane: (2012)

PB1951: PROGNOSTIC SIGNIFICANCE OF CLINICAL INDICATORS RELATED TO AMINO ACID METABOLISM IN CHRONIC LYMPHOCYTIC LEUKEMIA
od: Ming Liu, i wsp.
Wydane: (2023-08-01)

Drug cross-resistance and therapy-induced resistance in chronic lymphocytic leukaemia by an enhanced method of individualised tumour response testing.
od: Bosanquet, A, i wsp.
Wydane: (2009)

A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia
od: Pavel Vodárek, i wsp.
Wydane: (2023-03-01)

Histocompatibility antigens (HLA) in acute lymphocytic leukemia
od: L Ulukutlu, i wsp.
Wydane: (1986-04-01)

UK Medical Research Council CLL3 - A randomized trial of the addition of epirubicin to standard chlorambucil treatment.
od: Catovsky, D, i wsp.
Wydane: (2000)

Clinical significance of serum sCD23 and B-cell maturation antigen levels in patients with chronic lymphocytic leukemia
od: Talib Mohammed Ameen, i wsp.
Wydane: (2022-01-01)

PB1871: PROGNOSTIC SIGNIFICANCE OF THE NOTCH1 GENE MUTATION AND OTHER LABORATORY FACTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
od: D. Krauchanka, i wsp.
Wydane: (2022-06-01)

Morphological and immunofenotypic features of the monoclonal population of B-lymphocytes in chronic lymphocytic leukemia
od: N. K. Guskova, i wsp.
Wydane: (2020-08-01)

Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3
od: Catovsky, D, i wsp.
Wydane: (1998)

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia
od: Masternak M, i wsp.
Wydane: (2020-10-01)

Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
od: Xixi Xiang, i wsp.
Wydane: (2023-01-01)

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
od: Yixin Zou, i wsp.
Wydane: (2018-11-01)

The combination of fludarabine and cyclophosphamide has a beneficial effect on the incidence of hemolytic anemia in chronic lymphocytic leukemia. Results from the UK LRF CLL4 trial
od: Dearden, C, i wsp.
Wydane: (2007)

PB1957: PROGNOSTIC SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGHV-U IN THE ERA OF NOVEL AGNETS; REAL-LİFE DATA
od: Fatma Arikan, i wsp.
Wydane: (2023-08-01)

NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases
od: Yixin Zou, i wsp.
Wydane: (2018-05-01)

Prognostic significance of lymphocyte recovery in children with standard and high-risk precursor B acute lymphoblastic leukemia
od: Rahul Naithani, i wsp.
Wydane: (2019-08-01)

CHARACTERIZATION OF BLAST CELLS IN CHRONIC GRANULOCYTIC-LEUKEMIA IN TRANSFORMATION, ACUTE MYELOFIBROSIS AND UNDIFFERENTIATED LEUKEMIA .2. STUDIES WITH MONOCLONAL-ANTIBODIES AND TERMINAL TRANSFERASE
od: Miguel, J, i wsp.
Wydane: (1985)

Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia
od: Paolo Strati, i wsp.
Wydane: (2017-01-01)

Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia
od: Elisa ten Hacken, i wsp.
Wydane: (2017-10-01)